Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
1 clinical trials · Condition
◉ Watch Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
| Record | Firm | Date |
|---|---|---|
| Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer (NCT03257761) | University of Southern California | 2018-02-07 |
Track Extrahepatic Bile Duct Adenocarcinoma, Biliary Type automatically
Every clearance here is in the API, with alerts when new ones post.